Grants and Contributions:
Title:
Biologics for the treatment of wound infections
Agreement Number:
905608
Agreement Value:
$300,000.00
Agreement Date:
Apr 2, 2018 - Aug 30, 2019
Description:
Phagelux (Canada) Inc. is developing unique delivery technologies of novel biologics to tackle multi-drug resistant infections in wounds. The goal of the project is to scale-up the production of the various components of the delivery system in an effort to comply to regulatory requirements for pre-clinical and Phase I clinical studies.
Organization:
National Research Council Canada
Expected Results:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Location:
Mono, Quebec, CA H4P 2R2
Reference Number:
172-2018-2019-Q1-905608
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
807691589
Recipient Type:
For-profit organization
Additional Information:
This agreement has been amended 1 time(s). The end date of this agreements has been modified by 63 days.
Amendment Date
Jun 20, 2019
Recipient's Legal Name:
Phagelux ( Canada ) Inc.
Federal Riding Name:
Mount Royal
Federal Riding Number:
24052
Program:
Industrial Research Assistance Program – Contributions to Firms
Program Purpose:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Coverage:
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.
NAICS Code:
325410
Amendments: